30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Cutting Edge Spine Gains FDA Clearance of EVOLha-DLIF -

Cutting Edge Spine (CES) received FDA 510(k) clearance of the EVOL®ha-DLIF direct lateral interbody fusion system, its latest addition to a bioactive device portfolio. Product launch is underway. Like the company's EVOLha-C, EVOLha-ALIF and EVOSha, EVOLha-DLIF is made of PEEK-OPTIMA HA Enhanced material from Invibio Biomaterial Solutions. CES implants made with this material have demonstrated early onset bone formation and apposition to its implants.